OMGA

Omega Therapeutics, Inc.

3.58 USD
-0.01 (-0.14%)
Last updated
This page is just a preview of the data found in TrendSpider’s full version

Omega Therapeutics, Inc. stock is up 2.29% since 30 days ago. The next earnings date is Mar 8, 2024. The company has had below-average volume in the last 30 days. Its seasonality going into this month shows a chance of a red month, as 33.33% of the previous 2 February’s closed higher than January.

About Omega Therapeutics, Inc.

Omega Therapeutics, Inc. operates as a development-stage biopharmaceutical company. Its OMEGA Epigenomic Programming platform is designed to coopt nature's operating system by harnessing the power of epigenetics, the mechanism for gene control and cell differentiation. The company was incorporated in 2016 and is headquartered in Cambridge, Massachusetts.